Your Search Returned 283 tagged news reports
Sprout Pharmaceutical has not lost desire for its female sex pill. Despite receiving a complete response letter from the FDA, the little drugmaker is appealing the agency decision. Nonetheless, the agency decision is only the latest instance in which
The 15-year search for a pill that boosts sexual desire in women has hit another roadblock, raising questions about the future of efforts to develop a female equivalent to Viagra. Sprout Pharmaceuticals said Wednesday it has reached an impasse with
It's hard out there for a rule-flouting, heavily financed disruptor. If it's not government regulators, then it's "frivolous lawsuits," amiright? This time, it's a class action lawsuit filed in California accusing 23andMe of "falsely and misleadingly"
The tablets are a new formulation with a loading dose of 300mg (three 100mg delayed-release tablets) twice daily on the first day, followed by a once-daily maintenance dose of 300mg starting on the second day of therapy. The company also markets
Jetlag can often be a headache, literally, for those who travel through different time zones. The leading travel search site Tianxun.cn conducted a survey on the most popular methods to tackle jetlag among 1,000 airline passengers. A light diet and
Therefore it stands to reason that when you are dealing with a product with a Boxed Warning in its label, extra care needs to be taken with regard to communications because if there is a violation, it would appear that there is a greater tendency for
The Lombardy region in northwestern Italy leads the country in the volume sold of the medication Viagra, while central Emilia Romagna reports the greatest per capita annual sales, according to figures released Wednesday. As the medication to treat
Somewhat surprisingly, analysts have seemed to get more optimistic about Ariad earnings recently. They've kept near-term estimates steady, but in just the past month, they've narrowed their loss projections by a quarter per share. The stock, though,
Now that the FDA has told them to take the drug off the market completely, it was clear what was going to happen. Happen it has: the company is laying off a large part of its workforce. It's very much in doubt whether Inclusig will ever come back.
A day after suspending sales of its cancer drug Iclusig, Ariad Pharmaceuticals said it has adopted a shareholder rights plan often called a poison pill'' a move that could help the company fend off a takeover. Ariad said owners of its shares will be